<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04782908</url>
  </required_header>
  <id_info>
    <org_study_id>HERACLES-HFpEF</org_study_id>
    <nct_id>NCT04782908</nct_id>
  </id_info>
  <brief_title>Hemodynamic Implications of Transcatheter Tricuspid Valve Repair in HFpEF Patients</brief_title>
  <acronym>HERACLES-HFpEF</acronym>
  <official_title>Hemodynamic Characterisation of Patients Undergoing Transcatheter Tricuspid Valve Edge-to-edge Repair in Patients With Severe Tricuspid Regurgitation and Heart Failure With Preserved Ejection Fraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart Center Leipzig - University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heart Center Leipzig - University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the pathophysiological implications of transcatheter&#xD;
      tricuspid valve edge-to-edge repair in patient with heart failure and preserved ejection&#xD;
      fraction and severe tricuspid regurgitation. Changes in right- and left-ventricular function&#xD;
      as well as the interventricular dependence will be analysed on a multimodal basis including&#xD;
      pressure-volume loop analysis and cardiac magnetic resonance imaging.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients undergoing transcatheter tricuspid valve edge-to-edge repair will undergo multimodal cardiovascular diagnostics before and after tricuspid valve repair including pressure volume loop analysis and cardiac magnetic resonance imaging</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Outcome assessors will be blinded whether they are analysing pre or post transcatheter tricuspid valve edge-to-edge repair data.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Periprocedural change in enddiastolic pressure volume relationship of the left ventricle</measure>
    <time_frame>Periprocedural.</time_frame>
    <description>Change in the ratio of pressure to volume of the left ventricle before and after TTVR. Measurement will take place during TTVR with patient in general anesthesia. Measures will be made using a commercially available conductance catheter. Data analysis will be performed offline using a dedicated software.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the estimated left ventricular end diastolic volume at 10 mmHg as estimated by the left ventricular pressure volume relationship (LVEDPVR)</measure>
    <time_frame>Periprocedural.</time_frame>
    <description>Measurement will take place during TTVR with patient in general anesthesia. Measures will be made using a commercially available conductance catheter. Data analysis will be performed offline using a dedicated software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the ratio of isovolumetric relaxation constant &quot;Tau&quot; and duration of diastole of the left ventricle.</measure>
    <time_frame>Periprocedural.</time_frame>
    <description>Measurement will take place during TTVR with patient in general anesthesia. Measures will be made using a commercially available conductance catheter. Data analysis will be performed offline using a dedicated software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dPdtmin</measure>
    <time_frame>Periprocedural.</time_frame>
    <description>Measurement will take place during TTVR with patient in general anesthesia. Measures will be made using a commercially available conductance catheter. Data analysis will be performed offline using a dedicated software.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the early diastolic filling pattern as assessed by MRI.</measure>
    <time_frame>Baseline and 1-month follow-up following TTVR.</time_frame>
    <description>All patients will receive MRI before and 1-month after TTVR on a 1.5 tesla scanner.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Congestive Heart Failure</condition>
  <condition>Tricuspid Regurgitation</condition>
  <arm_group>
    <arm_group_label>Transcatheter tricuspid valve edge-to-edge repair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo transcatheter tricuspid valve edge-to-edge repair (TTVR) and hemodynamic characteristics will be analysed on a multimodal approach using cardiac magnetic resonance imaging and pressure volume loop analysis before and after TTVR.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcatheter tricuspid valve edge-to-edge repair</intervention_name>
    <description>Transcatheter tricuspid valve edge-to-edge repair is an interventional approach to treat severe tricuspid regurgitation. Under general anesthesia a clip delivery system is forwarded through the vena femoralis and right atrium in the right ventricle. A clip is deployed to clamp the tricuspid valve and reduce tricuspid valve regurgitation.</description>
    <arm_group_label>Transcatheter tricuspid valve edge-to-edge repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Severe tricuspid regurgitation with need for interventional treatment approach as&#xD;
             decided by an interdisciplinary heart team.&#xD;
&#xD;
          -  Signs and symptoms of left-sided heart failure.&#xD;
&#xD;
          -  Left-ventricular ejection fraction ≥50%&#xD;
&#xD;
          -  Invasive evidence of elevated left-ventricular fillings pressures (pulmonary capillary&#xD;
             wedge pressure [PCWP] or left-ventricular end-diastolic pressure ≥15 mmHg)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant relevant mitral valve regurgitation with need for concomitant&#xD;
             interventional treatment&#xD;
&#xD;
          -  Moderate aortic stenosis.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Contraindication to perform cardiac magnetic resonance imaging.&#xD;
&#xD;
          -  Conditions rendering patient unable to give informed consent to the study protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karl-Patrik Kresoja, MD</last_name>
    <phone>0341865252596</phone>
    <email>karl-patrik.kresoja@medizin.uni-leipzig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philipp Lurz, MD, PhD</last_name>
    <phone>0341865252529</phone>
    <email>philipp.lurz@medizin.uni-leipzig.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Centre at University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Saxony</state>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl-Patrik Kresoja, MD</last_name>
      <phone>0341 865 252596</phone>
      <email>karl-patrik.kresoja@medizin.uni-leipzig.de</email>
    </contact>
    <contact_backup>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <phone>0341 865 252529</phone>
      <email>philipp.lurz@medizin.uni-leipzig.de</email>
    </contact_backup>
    <investigator>
      <last_name>Karl-Philipp Rommel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Besler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Unterhuber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 1, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2021</study_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heart Center Leipzig - University Hospital</investigator_affiliation>
    <investigator_full_name>Philipp Lurz</investigator_full_name>
    <investigator_title>Professor, Managing Senior Physician</investigator_title>
  </responsible_party>
  <keyword>Heart failure with preserved ejection fraction</keyword>
  <keyword>tricuspid regurgitation</keyword>
  <keyword>transcatheter tricuspid valve edge-to-edge repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Anonymized data will be made available on reasonable cooperation request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

